Current 2026 Blood Bank Policies on GLP-1 Donor Eligibility Plasma collection centers follow FDA and AABB (American Association of Blood Banks) guidance, which categorizes GLP-1 medications as temporary deferrals rather than permanent exclusions
Additionally, semaglutide acts on appetite centers in the brain, reducing hunger and promoting satiety, which contributes to significant weight loss in many patients
Our study aimed to characterize and evaluate AP associated with different GLP-1 RAs (exenatide, lixisenatide, liraglutide, albiglutide, semaglutide, dulaglutide and tirzepatide) in a public adverse events database and to review the relevant case reports
The Microdose Protocol starts at lower doses to minimize gastrointestinal disruption while your body adapts, reducing the severity of side effects experienced compared to standard-dose initiation